Prostate cancer specific mortality after 5α-reductase inhibitors medication in benign prostatic hyperplasia patients: systematic review and meta-analysis-Reference-Cited by-同舟云学术

Prostate cancer specific mortality after 5α-reductase inhibitors medication in benign prostatic hyperplasia patients: systematic review and meta-analysis

Published:2021-01-01 Issue:1 Volume:24 Page:80-91
ISSN:1368-5538
Container-title:The Aging Male
language:en
Short-container-title:The Aging Male

Author:

Park Jae Joon¹,Lee Hyun Young¹,Shim Sung Ryul²,Lee Sang Wook³,Kim Kwang Taek⁴,Kim Jae Heon¹

Affiliation:

1. Department of Urology, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea

2. Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea

3. Department of Urology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea

4. Department of Urology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea

Funder

Soonchunhyang University Research Fund

Publisher

Informa UK Limited

Subject

Geriatrics and Gerontology

Link

https://www.tandfonline.com/doi/pdf/10.1080/13685538.2021.1948993

Reference26 articles.

1. Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location

2. A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges

3. The Influence of Finasteride on the Development of Prostate Cancer

4. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia

5. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiandrogens as Therapies for COVID-19: A Systematic Review;Cancers;2024-01-10

2. 5-alpha reductase inhibitors use in prostatic disease and beyond;Translational Andrology and Urology;2023-03